Rare diseases
Investigational molecules
Locations
Back to Poland81 clinical trials in Ostrowiec Swietokrzyski, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
PolandA Phase 2a Study of ly4005130 in Adults with Severe Alopecia Areata
PolandStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
PolandEfficacy and Safety of LY4005130 Compared with Placebo in Adults with Non‑Segmental Vitiligo
PolandStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
PolandLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
PolandStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
PolandLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
PolandStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
PolandA Study of S-337395 for Adults Not in Hospital with Respiratory Syncytial Virus Who Are at High Risk of Severe Disease
PolandStudy of abrocitinib oral suspension for children aged 2 years and older with moderate to severe atopic dermatitis to evaluate long-term safety and effectiveness
PolandStudy of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease
PolandThe busiest research cities in the country
What the registry says about research in the country
Important clinical research focusing on asthma and COPD management, including trials evaluating new inhaler formulations and innovative treatments for severe cases.
Studies include evaluation of triple therapy combinations and novel biological treatments for better disease control.
Comprehensive research into various skin conditions, with particular focus on atopic dermatitis, psoriasis, and other inflammatory skin disorders.
Trials examine both topical and systemic treatments, including novel biological therapies.
Innovative studies targeting atherosclerotic cardiovascular disease, focusing on prevention and treatment of major cardiovascular events.
Research includes evaluation of new compounds for managing cholesterol levels and preventing cardiovascular complications.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
